Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Morton

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|May 27, 2005
Activation and antitumor activity of CPT-11 in plasma esterase-deficient miceChristopher L Morton, Lisa Iacono, Janice L Hyatt, et al.
Molecular Pharmacology|May 25, 2004
Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activityRandy M Wadkins, Janice L Hyatt, Kyoung Jin P Yoon, et al.
Chemico-Biological Interactions|November 1, 2005
Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11Janice L Hyatt, Lyudmila Tsurkan, Christopher L Morton, et al.
Journal of Pediatric Surgery|January 3, 2025
Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts<sup>☆</sup>Daniel B Gehle, Carolyn M Jablonowski, Prahalathan Pichavaram, et al.
Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|June 29, 2010
Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing programChristopher L Morton, Peter J Houghton, E Anders Kolb, et al.
Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.
Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Science Advances|January 30, 2016
Regulated lysosomal exocytosis mediates cancer progressionEda Machado, Shai White-Gilbertson, Diantha van de Vlekkert, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|May 27, 2005
Activation and antitumor activity of CPT-11 in plasma esterase-deficient miceChristopher L Morton, Lisa Iacono, Janice L Hyatt, et al.
Molecular Pharmacology|May 25, 2004
Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activityRandy M Wadkins, Janice L Hyatt, Kyoung Jin P Yoon, et al.
Chemico-Biological Interactions|November 1, 2005
Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11Janice L Hyatt, Lyudmila Tsurkan, Christopher L Morton, et al.
Journal of Pediatric Surgery|January 3, 2025
Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts<sup>☆</sup>Daniel B Gehle, Carolyn M Jablonowski, Prahalathan Pichavaram, et al.
Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|June 29, 2010
Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing programChristopher L Morton, Peter J Houghton, E Anders Kolb, et al.
Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.
Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Science Advances|January 30, 2016
Regulated lysosomal exocytosis mediates cancer progressionEda Machado, Shai White-Gilbertson, Diantha van de Vlekkert, et al.
Pageof 10